Legal & General Group
AGN

Legal & General Group’s Allergan Inc AGN Stock Holding History

Legal & General Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,200,796
Closed -$255M – 2833
2014
Q4 		$255M Sell
1,200,796
-41,236
-3% -$8.2M 0.3% 77
2014
Q3 		$221M Sell
1,242,032
-44,625
-3% -$7.41M 0.27% 85
2014
Q2 		$218M Sell
1,286,657
-898
-0.1% -$140K 0.25% 94
2014
Q1 		$160M Sell
1,287,555
-3,007
-0.2% -$366K 0.19% 121
2013
Q4 		$143M Buy
1,290,562
+7,454
+0.6% +$712K 0.17% 139
2013
Q3 		$116M Sell
1,283,108
-56,286
-4% -$5.05M 0.15% 154
2013
Q2 		$113M Buy
+1,339,394
New +$139M 0.16% 151

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Legal & General Group's AGN Position: Q1 2015 in Review

Legal & General Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,200,796 shares — an estimated $255M sold.

Legal & General Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $255M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Legal & General Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Legal & General Group sold 1,200,796 Allergan Inc shares in Q1 2015, an estimated $255M.
  • Legal & General Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Legal & General Group's Allergan Inc position peaked at $255M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Legal & General Group's 13F filing for Q1 2015, filed 14 May 2015.